Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

Add a description, image, and links to the molecule-driver topic page so that developers can more easily learn about it.

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Scopolamine Transdermal System 1 mg/3 days ... Zydus has been ...

New Delhi: Zydus Lifesciences Ltd on Friday said it has received the final approval from the US Health regulator to market its Scopolamine transdermal system indicated to prevent nausea and ...

Zydus Lifesciences Ltd on Friday said it has received the final approval from the US Health regulator to market its Scopolamine transdermal system indicated to prevent nausea and vomiting under ...

Zydus Lifesciences Ltd has received USFDA approval to market its Scopolamine transdermal system, which helps prevent nausea and vomiting under various conditions, including after surgery and due to ...

MUMBAI: Zydus Lifesciences Limited received the final nod from the United States Food and Drug Administration (USFDA) to market its Scopolamine Transdermal System, delivering 1 mg of the ...

"They're interested in making thousands of derivatives to fine-tune a molecule's structure and performance, so we teamed up with the pharmaceutical companies to really explore the power of it ...

This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site http://www.editorialmanager ...

More than two decades ago, a research team in the lab of David Hafler, a Yale researcher who at the time was at Harvard, discovered a type of T cell in humans that suppresses the immune system; they ...